Quality of Life Improvement with Sublingual Immunotherapy : A Prospective Study of Efficacy

Abstract EN

Due to its excellent safety profile, ease of administration, and economic considerations, sublingual immunotherapy (SLIT) is becoming a preferred form of allergen specific immunotherapy.

The efficacy of SLIT is still debated.

The purpose of this act of practice trial is to evaluate quality of life outcomes in patients treated with SLIT.

Fifty one patients with allergic rhinoconjunctivitis demonstrated by skin testing completed the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) at initiation, at four months and at 10–12 months of SLIT.

Significant improvement (P<0.05) on six of seven domain categories of the RQLQ questionnaire was noted.

Total RQLQ scores also showed significant improvement.

This study supports SLIT as a modality effective in controlling allergic symptoms.